GLP-1 drug for fertility in obese women with PCOS
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if a GLP-1 medicine (a type of diabetes drug that also helps with weight) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who wants to become pregnant.
- You have PCOS diagnosed by the Rotterdam criteria (a standard set of symptoms).
- Your body mass index (BMI) is between 28 and 35 (inclusive of 28, but less than 35).
- You are between 18 and 40 years old.
- You do not have other medical conditions that make pregnancy unsafe, and you have not used certain hormones or weight loss drugs in the last 3 months.
- You have not had weight loss surgery, and you do not have severe male factor infertility (like no sperm or very poor sperm quality) requiring donor sperm or genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a GLP-1 medication (a type of diabetes drug that also helps with weight loss) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial might be an option for you.
This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.
This study tests if a specific diet can help women with PCOS who are overweight. It looks at weight, hormone balance, and menstrual health over several months.
This study tests if a special way of giving a fertility drug (FSH) can improve pregnancy chances in women with obesity who are having trouble conceiving. It aims to understand how the drug affects reproductive health.
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
This study looks at fertility in women with polycystic ovary syndrome (PCOS) compared to women without it, to better understand how PCOS affects fertility. If you have PCOS or have normal hormones and metabolism, and you were part of a previous study called METABOPK, you may be able to join.
Hear when a new Polycystic Ovary Syndrome (PCOS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.